Shortage of dextroamphetamine tablets

The American Society of Health-System Pharmacists reports a shortage of dextroamphetamine tablets. Teva is the sole supplier approved by the FDA, and gave no reason for the shortage. It seem likely, however, that this shortage is a continuing effect of the ongoing shortages of amphetamine mixed salts and methylphenidate. All of these are used to treat attention-deficit hyperactivity disorder.

Shortage of amphetamine mixed salts, immediate-release tablets

The American Society of Health-System Pharmacists reports a shortage of amphetamine mixed salts, immediate-release tablets. This mixture of amphetamine and dextroamphetamine salts is used to treat attention-deficit hyperactivity disorder. If the person with ADHD is not already self-medicating with alcohol, marijuana or illicit drugs, these amphetamines may prevent substance abuse. Amphetamine abuse is another risk, of course, along with cardiac/cardiovascular complications.